Monthly Cost Breakdown: Wegovy vs Mounjaro Investment
Wegovy vs Mounjaro vs Ozempic: Understanding Monthly Cost Differences
The monthly cost for Wegovy or Mounjaro varies dramatically depending on your treatment phase, making budgeting essential for long-term success. Wegovy follows a mandatory 16-week dose escalation, starting at £79.99 monthly for the 0.25mg starter dose and reaching £209.99 monthly for the 2.4mg maintenance dose. Mounjaro presents a similar cost structure with its tirzepatide formulation, though specific pricing may differ based on dose strength and supplier arrangements. Ozempic, whilst containing the same semaglutide active ingredient as Wegovy, remains licensed exclusively for type 2 diabetes treatment—promoting Ozempic for weight management constitutes illegal off-label advertising in the UK.
Both Wegovy and Mounjaro require prescription-only medicine status with clinical assessment through our GPhC-registered pharmacy (#9012878). The key difference lies in their mechanisms: Wegovy targets GLP-1 receptors exclusively, whilst Mounjaro acts as a dual GIP and GLP-1 receptor agonist. Your monthly investment reflects not just the medication cost, but access to cold-chain storage, next-day delivery, and ongoing prescriber support throughout your weight management journey.
Complete Pricing Structure: Wegovy and Mounjaro Monthly Costs
Understanding the complete cost progression helps you budget effectively for sustainable weight management. Wegovy pricing starts with Month 1 at £79.99 (0.25mg dose), progressing to £94.99 for Months 2-3 (0.5mg), then £99.99 for Months 4-5 (1mg), followed by £139.99 for Month 6 (1.7mg), before reaching the maintenance cost of £209.99 monthly from Month 7 onwards (2.4mg). New customers benefit from code FIRST40 applied at checkout, whilst returning customers use code DOSE25 to maintain optimal pricing throughout their treatment. Our Getting Started bundles, such as the Intro Duo at £169.99, provide convenient two-month supplies whilst maintaining the same per-pen pricing structure.
For those requiring extended treatment periods, our Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, ensuring uninterrupted access to your prescription-only medicine. Annual maintenance costs at the therapeutic dose total approximately £2,520, representing a significant but manageable investment in long-term health outcomes. Both Wegovy and Mounjaro are available through EverydayMeds with identical ordering processes and delivery standards, allowing your prescriber to help determine which treatment aligns best with your clinical needs and monthly budget considerations.
Clinical Evidence Supporting Wegovy vs Mounjaro Investment
The STEP clinical trial programme demonstrates why Wegovy represents a worthwhile monthly investment for eligible patients. In STEP 1, participants taking Wegovy alongside diet and exercise achieved an average weight loss of approximately 15% at 68 weeks, compared to 2.4% with placebo. The recent SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events, adding significant health economic value to the monthly cost consideration.
Mounjaro's SURMOUNT trials similarly demonstrate substantial efficacy with the dual GIP and GLP-1 mechanism, though direct comparison between Wegovy or Mounjaro weight loss outcomes isn't appropriate due to different trial designs and populations. Both treatments require ongoing monthly investment as the STEP 1 extension study showed patients regained approximately two-thirds of weight lost within one year of stopping treatment, emphasising that weight management represents a long-term commitment rather than a short-term solution.
How Wegovy and Mounjaro Work: Understanding Your Monthly Investment
Your monthly cost for Wegovy or Mounjaro reflects access to sophisticated GLP-1 receptor agonist technology that mimics natural fullness hormones in your digestive system. Wegovy's semaglutide acts exclusively on GLP-1 receptors in your brain's appetite centres, reducing hunger signals and promoting satiety after smaller meals. Mounjaro's tirzepatide targets both GIP and GLP-1 receptors, potentially offering enhanced metabolic effects through its dual mechanism approach. Both treatments may help reduce food cravings and emotional eating patterns that contribute to weight regain. The monthly investment covers not just the active pharmaceutical ingredient, but the sophisticated FlexTouch pen delivery system that ensures accurate, comfortable weekly injections. This prescription-only medicine approach ensures clinical oversight throughout your treatment, justifying the monthly cost through ongoing safety monitoring and dose optimisation support.
Streamlined Ordering Process for Wegovy or Mounjaro
Accessing either Wegovy or Mounjaro through EverydayMeds involves a straightforward three-step process that justifies the monthly cost through convenience and clinical safety. Complete our comprehensive 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our qualified prescribers review your assessment within 3 working days (or 24 hours with express service), ensuring appropriate clinical oversight for this prescription-only medicine. Once approved, your Wegovy or Mounjaro ships via next-day delivery using cold-chain temperature-controlled packaging to maintain medication stability. Our GPhC-registered pharmacy (#9012878) handles all aspects of prescription management, from initial clinical review through ongoing prescription renewals and dose adjustments. This comprehensive service justifies the monthly investment through professional oversight, convenience, and assured medication authenticity throughout your weight management journey.
Storage and Practical Considerations: Wegovy vs Mounjaro
Understanding storage requirements helps maximise your monthly investment in either Wegovy or Mounjaro treatment. Both medications require refrigerated storage at 2-8°C before first use, though Wegovy offers superior travel convenience with 6 weeks room temperature stability compared to Mounjaro's 21-day limit. The FlexTouch pen system used by Wegovy provides intuitive dose administration with clear dose windows and audible click confirmation for each injection. Mounjaro utilises similar pen technology with comparable ease of use for weekly injections. Both treatments follow mandatory dose escalation protocols over 16 weeks, preventing you from skipping doses or accelerating progression regardless of tolerance. Your monthly cost includes access to comprehensive injection technique resources and ongoing clinical support to optimise treatment outcomes while minimising potential side effects.
Long-term Budgeting for Wegovy or Mounjaro Treatment Success
Planning your annual budget for Wegovy or Mounjaro ensures sustainable access to these life-changing treatments without financial strain. The escalation phase spans approximately 4 months with total costs around £514 for Wegovy, followed by maintenance costs of £209.99 monthly thereafter. Strategic use of our Getting Started bundles during escalation phases reduces order frequency whilst maintaining competitive pricing throughout dose progression. Returning customers benefit from code DOSE25 throughout their treatment journey, ensuring ongoing value for long-term weight management success.
Consider the broader health economic benefits when evaluating monthly costs for Wegovy or Mounjaro treatment. Successful weight management may reduce healthcare costs associated with obesity-related conditions including type 2 diabetes, cardiovascular disease, and joint problems. The SELECT trial's demonstrated cardiovascular benefits suggest potential long-term savings that offset monthly medication costs. Both Wegovy and Mounjaro are available from EverydayMeds with identical payment options and delivery schedules, allowing your prescriber to help determine which treatment offers optimal value for your specific clinical situation and financial considerations.
Making Your Wegovy or Mounjaro Investment Today
Starting your weight management journey with either Wegovy or Mounjaro represents an investment in long-term health outcomes that extends far beyond monthly medication costs. New customers can begin with code FIRST40 applied at checkout, whilst our clinical team provides ongoing support throughout dose escalation and maintenance phases. Visit https://everydaymeds.co.uk/collections/wegovy to complete your clinical assessment and begin treatment within days of approval. Our GPhC-registered pharmacy (#9012878) ensures clinical excellence and medication authenticity for every prescription dispensed. Remember that weight management success requires combining your chosen treatment with a reduced-calorie diet and increased physical activity for optimal results. Both Wegovy and Mounjaro are available from EverydayMeds—your prescriber can help determine which treatment aligns best with your clinical needs, lifestyle preferences, and monthly budget considerations.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
